
Abintus Bio
Pioneering in vivo genetic medicines to engineer immune cells directly inside the body for treating lymphoma and solid tumors.
Employees
Enterprise value
$63—94m
Authorizing premium user...
Pioneering in vivo genetic medicines to engineer immune cells directly inside the body for treating lymphoma and solid tumors.